OxitopePharma_Logo.jpg
Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury
28 nov. 2022 07h00 HE | Oxitope Pharma
PRESS RELEASE Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury Naarden, The Netherlands, 28 November 2022 – Oxitope Pharma B.V....
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
16 mars 2021 08h30 HE | Healthtech Solutions, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury.  A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW...